[1]
M. N. Milosavljević, S. M. Jankovic, A. V. Pejčić, J. R. Milovanović, V. D. Opančina, and M. J. Kostić, “Reslizumab versus placebo for poorly controlled, severe eosinophilic asthma: meta-analysis”, Vojnosanit Pregl, vol. 75, no. 9, Dec. 2020, doi: 10.2298/VSP161124013M.